Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

Completed · Not applicable

Conditions studied: Atrial Fibrillation, Arrhythmias, Cardiac, Atrial Flutter

In brief

This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.

Key facts

Study ID

NCT03769207

Run by

Apple Inc.

People needed

17

Starts

2018-12-08

Expected to finish

2019-08-20

Last updated by the study team

2020-10-20

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Possession of the following at time of eligibility screening:
• iPhone (5s or later) with iOS version 12.1.1 or later defined as iPhone model/iOS version used to complete screening eligibility.
• Apple Watch (Series 1-4) with watchOS version 5.1.2 or later defined as Apple Watch model/watchOS paired with iPhone used to complete screening eligibility
• At least one of the following by self-report before consent:
• Irregular Rhythm Notification
• ECG app classification of Atrial Fibrillation
• ECG app classification of Inconclusive defined as "Inconclusive," "Heart Rate Over 120," or "Heart Rate Under 50"
• Age ≥ 22 years at time of eligibility screening
• Current resident of the United States at time of eligibility screening, and will reside in the United States for the length of the study
• Proficient in written and spoken English
• Valid phone number associated with iPhone, ascertained from self-report
• Valid email address, ascertained from self-report

You may not qualify if…

• Shared iCloud account
• Shared AppleWatch

Where it is running

• Stanford University — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.